NCT02996760View on ClinicalTrials.gov

Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.

PHASE3TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 14, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Endometrial Development
Interventions
DRUG

Growth Factor, Platelet-Derived

0,5 mL, vaginal use , 3 dose number

Trial Locations (1)

48940

IVI Bilbao, Leioa

Sponsors

Lead Sponsor

IVI Bilbao
All Listed Sponsors
lead

IVI Bilbao

OTHER

NCT02996760 - Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction. | Biotech Hunter | Biotech Hunter